Literature DB >> 9837822

Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families.

J T Wang1, C J Lin, S M Burridge, G K Fu, M Labuda, A A Portale, W L Miller.   

Abstract

Vitamin D-dependent rickets type I (VDDR-I), also known as pseudo-vitamin D-deficiency rickets, appears to result from deficiency of renal vitamin D 1alpha-hydroxylase activity. Prior work has shown that the affected gene lies on 12q13.3. We recently cloned the cDNA and gene for this enzyme, mitochondrial P450c1alpha, and we and others have found mutations in its gene in a few patients. To determine whether all patients with VDDR-I have mutations in P450c1alpha, we have analyzed the P450c1alpha gene in 19 individuals from 17 families representing various ethnic groups. The whole gene was PCR amplified and subjected to direct sequencing; candidate mutations were confirmed by repeat PCR of the relevant exon from genomic DNA from the patients and their parents. Microsatellite haplotyping with the markers D12S90, D12S305, and D12S104 was also done in all families. All patients had P450c1alpha mutations on both alleles. In the French Canadian population, among whom VDDR-I is common, 9 of 10 alleles bore the haplotype 4-7-1 and carried the mutation 958DeltaG. This haplotype and mutation were also seen in two other families and are easily identified because the mutation ablates a TaiI/MaeII site. Six families of widely divergent ethnic backgrounds carried a 7-bp duplication in association with four different microsatellite haplotypes, indicating a mutational hot spot. We found 14 different mutations, including 7 amino acid replacement mutations. When these missense mutations were analyzed by expressing the mutant enzyme in mouse Leydig MA-10 cells and assaying 1alpha-hydroxylase activity, none retained detectable 1alpha-hydroxylase activity. These studies show that most if not all patients with VDDR-I have severe mutations in P450c1alpha, and hence the disease should be referred to as "1alpha-hydroxylase deficiency."

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837822      PMCID: PMC1377641          DOI: 10.1086/302156

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  44 in total

Review 1.  Site-directed mutagenesis using double-stranded plasmid DNA templates.

Authors:  J Braman; C Papworth; A Greener
Journal:  Methods Mol Biol       Date:  1996

2.  High-resolution crystal structure of cytochrome P450cam.

Authors:  T L Poulos; B C Finzel; A J Howard
Journal:  J Mol Biol       Date:  1987-06-05       Impact factor: 5.469

3.  Unique biosynthesis by kidney of a biological active vitamin D metabolite.

Authors:  D R Fraser; E Kodicek
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

4.  Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.

Authors:  C R Scriver; T M Reade; H F DeLuca; A J Hamstra
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

5.  Site of 1,25(OH)2 vitamin D3 synthesis in the kidney.

Authors:  M G Brunette; M Chan; C Ferriere; K D Roberts
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

6.  Gene structure of human cytochrome P-450(SCC), cholesterol desmolase.

Authors:  K Morohashi; K Sogawa; T Omura; Y Fujii-Kuriyama
Journal:  J Biochem       Date:  1987-04       Impact factor: 3.387

7.  Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta.

Authors:  B C Chung; K J Matteson; R Voutilainen; T K Mohandas; W L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.

Authors:  T A Reinhardt; R L Horst; J W Orf; B W Hollis
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

9.  Localization of 25-hydroxyvitamin D3 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron.

Authors:  H Kawashima; S Torikai; K Kurokawa
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

10.  Vitamin D dependency: replacement therapy with calcitriol?

Authors:  E E Delvin; F H Glorieux; P J Marie; J M Pettifor
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406

View more
  34 in total

Review 1.  Vitamin D deficiency and rickets.

Authors:  R W Chesney
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec.

Authors:  Vania Yotova; Damian Labuda; Ewa Zietkiewicz; Dominik Gehl; Alan Lovell; Jean-François Lefebvre; Stéphane Bourgeois; Emilie Lemieux-Blanchard; Marcin Labuda; Hélène Vézina; Louis Houde; Marc Tremblay; Bruno Toupance; Evelyne Heyer; Thomas J Hudson; Claude Laberge
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

3.  Novel vitamin D 1α-hydroxylase gene mutations in a Chinese vitamin-D-dependent rickets type I patient.

Authors:  Lihua Cao; Fang Liu; Yu Wang; Jian Ma; Shusen Wang; Libo Wang; Yang Zhang; Chen Chen; Yang Luo; Hongwei Ma
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

4.  Transplantation of bone marrow-derived mesenchymal stem cells rescues partially rachitic phenotypes induced by 1,25-Dihydroxyvitamin D deficiency in mice.

Authors:  Zengli Zhang; Shaomeng Yin; Xian Xue; Ji Ji; Jian Tong; David Goltzman; Dengshun Miao
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 5.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

6.  Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction.

Authors:  D K Panda; D Miao; M L Tremblay; J Sirois; R Farookhi; G N Hendy; D Goltzman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 7.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

8.  Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations.

Authors:  Minjing Zou; Essa Y Baitei; Ali S Alzahrani; Ranjit S Parhar; Futwan A Al-Mohanna; Brian F Meyer; Yufei Shi
Journal:  Endocrine       Date:  2011-05-21       Impact factor: 3.633

9.  Drug off-target effects predicted using structural analysis in the context of a metabolic network model.

Authors:  Roger L Chang; Li Xie; Lei Xie; Philip E Bourne; Bernhard Ø Palsson
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

Review 10.  The initiation and prevention of multiple sclerosis.

Authors:  Alberto Ascherio; Kassandra L Munger; Jan D Lünemann
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.